• Research
  • About
  • Experts
Carnegie India logoCarnegie lettermark logo
AI
{
  "authors": [
    "Karim Sadjadpour"
  ],
  "type": "legacyinthemedia",
  "centerAffiliationAll": "dc",
  "centers": [
    "Carnegie Endowment for International Peace"
  ],
  "collections": [],
  "englishNewsletterAll": "menaTransitions",
  "nonEnglishNewsletterAll": "",
  "primaryCenter": "Carnegie Endowment for International Peace",
  "programAffiliation": "MEP",
  "programs": [
    "Middle East"
  ],
  "projects": [],
  "regions": [
    "Middle East",
    "Iran"
  ],
  "topics": [
    "Political Reform",
    "Nuclear Policy"
  ]
}

Source: Getty

In The Media

Iran is ‘Years Away’ from a Nuclear Weapon

Concern over Iran’s nuclear program often ignores the fact that Iran is still a significant amount of time from actually acquiring a nuclear weapon. This leaves policymakers with ample time to engage in diplomacy and develop coercive sanctions.

Link Copied
By Karim Sadjadpour
Published on Mar 9, 2012

Source: MSNBC's Morning Joe

Speaking on MSNBC's Morning Joe, Carnegie's Karim Sadjadpour stated that, as tensions between the Obama administration and Israel over Iran’s nuclear program continue, much discussion has focused on whether or not Iran can be counted on as a rational actor in international politics. Sadjadpour explained that “Iran is a rational actor in the sense that staying in power is paramount. The regime is homicidal but it is not suicidal.” However, it will ultimately prove extremely difficult to reach a modus vivendi with a regime that relies on anti-Americanism as an inextricable component of its ideology, Sadjadpour added.

One of the chief points of contention between the Obama administration and the Israelis centers on how far away Iran is from developing the capacity to weaponize its nuclear program. Sadjadpour said that the Iranians are at a minimum of two years before they will be able to have the bomb. “The reality is we often talk ourselves into hyperventilation on this issue, but there is still a significant amount of time to engage in diplomacy,”  he concluded.

About the Author

Karim Sadjadpour

Senior Fellow, Middle East Program

Karim Sadjadpour is a senior fellow at the Carnegie Endowment for International Peace, where he focuses on Iran and U.S. foreign policy toward the Middle East.

    Recent Work

  • Q&A
    What’s Keeping the Iranian Regime in Power—for Now

      Aaron David Miller, Karim Sadjadpour, Robin Wright

  • Q&A
    How Washington and Tehran Are Assessing Their Next Steps

      Aaron David Miller, David Petraeus, Karim Sadjadpour

Karim Sadjadpour
Senior Fellow, Middle East Program
Karim Sadjadpour
Political ReformNuclear PolicyMiddle EastIran

Carnegie India does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.

More Work from Carnegie India

  • Article
    Risk and Retaliation: Israel, Iran, and the Evolving Situation in West Asia

    An Israeli response to Iran’s October 1 attack is imminent. The key question is of its intensity and potential fallout, both within Iran, in terms of nuclear security policy changes, and across the broader region. The coming days are likely to reshape West Asia irreversibly.

      Gaddam Dharmendra

  • Commentary
    How WHO’s “One Health” Program Can Help India Tackle Monkeypox

    With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.

      Shruti Sharma

  • Paper
    Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in India

    In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.

      Shruti Sharma

  • Commentary
    Combating Vaccine Hesitancy in India

    Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.

      Shruti Sharma

  • Commentary
    How Should Countries Study Viruses Safely?

    The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?

      Shruti Sharma

Get more news and analysis from
Carnegie India
Carnegie India logo, white
Unit C-4, 5, 6, EdenparkShaheed Jeet Singh MargNew Delhi – 110016, IndiaPhone: 011-40078687
  • Research
  • About
  • Experts
  • Projects
  • Events
  • Contact
  • Careers
  • Privacy
  • For Media
Get more news and analysis from
Carnegie India
© 2026 Carnegie Endowment for International Peace. All rights reserved.